Literature DB >> 23180490

Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz.

Marc I Chimowitz1, David Fiorella, Colin P Derdeyn, Tanya N Turan, Bethany F Lane, Scott Janis, Michael J Lynn.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23180490      PMCID： PMC3748816          DOI： 10.1161/strokeaha.112.661041

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  18 in total

1.  Comment on: Stenting versus aggressive medical therapy for intracranial arterial stenosis : Chimowitz MI, Lynn MJ, Derdeyn CP, et al. N Engl J Med. 2011;365:993-1003.

Authors:  H Henkes; H Bäzner; P K Nelson
Journal:  Clin Neuroradiol       Date:  2011-11       Impact factor: 3.649

2.  Warning: side effects may include a decrease in invasive procedures.

Authors:  H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-17       Impact factor: 3.825

3.  The new standard for performance of intracranial angioplasty and stent placement after Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) Trial.

Authors:  S A Chaudhry; M Watanabe; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-17       Impact factor: 3.825

4.  Interpretation and implications of the prematurely terminated Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in the Intracranial Stenosis (SAMMPRIS) trial.

Authors:  Adnan I Qureshi
Journal:  Neurosurgery       Date:  2012-01       Impact factor: 4.654

5.  Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke.

Authors:  Amir Khan; Scott E Kasner; Michael J Lynn; Marc I Chimowitz
Journal:  Stroke       Date:  2012-02-23       Impact factor: 7.914

6.  Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?

Authors:  Michael P Marks
Journal:  Stroke       Date:  2012-01-12       Impact factor: 7.914

7.  Critique of "Stenting versus aggressive medical therapy for intracranial arterial stenosis" by Chimowitz et al in the new England Journal of Medicine.

Authors:  Alex Abou-Chebl; Helmuth Steinmetz
Journal:  Stroke       Date:  2012-01-12       Impact factor: 7.914

8.  Have medical therapy and stenting been fairly compared? A repercussion upon termination of recruitment in the SAMMPRIS trial.

Authors:  Thomas W Leung; Simon C H Yu; K S Lawrence Wong
Journal:  Int J Stroke       Date:  2011-08       Impact factor: 5.266

9.  US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.

Authors:  David Fiorella; Elad I Levy; Aquilla S Turk; Felipe C Albuquerque; David B Niemann; Beverly Aagaard-Kienitz; Ricardo A Hanel; Henry Woo; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

10.  Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Authors:  Marc I Chimowitz; Michael J Lynn; Colin P Derdeyn; Tanya N Turan; David Fiorella; Bethany F Lane; L Scott Janis; Helmi L Lutsep; Stanley L Barnwell; Michael F Waters; Brian L Hoh; J Maurice Hourihane; Elad I Levy; Andrei V Alexandrov; Mark R Harrigan; David Chiu; Richard P Klucznik; Joni M Clark; Cameron G McDougall; Mark D Johnson; G Lee Pride; Michel T Torbey; Osama O Zaidat; Zoran Rumboldt; Harry J Cloft
Journal:  N Engl J Med       Date:  2011-09-07       Impact factor: 91.245
View more
  1 in total

Review 1.  Intracranial stenting: SAMMPRIS.

Authors:  Colin P Derdeyn; David Fiorella; Michael J Lynn; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.